Clinical Trial Update: The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin [Phase 2]

View source ↗

Summary

A Phase 2 trial update examining whether HAART affects response to hepatitis C therapy with peginterferon alpha-2b and ribavirin in HIV/Hepatitis C coinfected p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Peginterferon alpha-2b (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hepatitis C | Phase 2 | Status: COMPLETED